| Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy A Kondo, K Shahpasand, R Mannix, J Qiu, J Moncaster, CH Chen, Y Yao, ... Nature 523 (7561), 431-436, 2015 | 431 | 2015 |
| Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer S Wei, S Kozono, L Kats, M Nechama, W Li, J Guarnerio, M Luo, MH You, ... Nature medicine 21 (5), 457-466, 2015 | 268 | 2015 |
| Localization of GRP78 to mitochondria under the unfolded protein response FC Sun, S Wei, CW Li, YS Chang, CC Chao, YK Lai Biochemical Journal 396 (Pt 1), 31, 2006 | 202 | 2006 |
| Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase SH Min, AW Lau, TH Lee, H Inuzuka, S Wei, P Huang, S Shaik, DY Lee, ... Molecular cell 46 (6), 771-783, 2012 | 166 | 2012 |
| PPARγ-independent antitumor effects of thiazolidinediones S Wei, J Yang, SL Lee, SK Kulp, CS Chen Cancer letters 276 (2), 119-124, 2009 | 128 | 2009 |
| Energy restriction as an antitumor target of thiazolidinediones S Wei, SK Kulp, CS Chen Journal of Biological Chemistry 285 (13), 9780-9791, 2010 | 90 | 2010 |
| The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation ML Luo, C Gong, CH Chen, H Hu, P Huang, M Zheng, Y Yao, S Wei, ... Cell reports 11 (1), 111-124, 2015 | 89 | 2015 |
| SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function CH Chen, CC Chang, TH Lee, ML Luo, P Huang, PH Liao, S Wei, FA Li, ... Cancer research 73 (13), 3951-3962, 2013 | 89 | 2013 |
| A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells S Wei, HC Yang, HC Chuang, J Yang, SK Kulp, PJ Lu, MD Lai, CS Chen Journal of Biological Chemistry 283 (39), 26759-26770, 2008 | 80 | 2008 |
| The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation M Nechama, J Kwon, S Wei, A Tun-Kyi, RS Welner, IZ Ben-Dov, ... Nature communications 9 (1), 1603, 2018 | 73 | 2018 |
| Peroxisome proliferator-activated receptor γ–independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation CC Yang, YC Wang, S Wei, LF Lin, CS Chen, CC Lee, CC Lin, CS Chen Cancer research 67 (7), 3229-3238, 2007 | 66 | 2007 |
| Thiazolidinediones modulate the expression of β-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase … S Wei, LF Lin, CC Yang, YC Wang, GD Chang, H Chen, CS Chen Molecular pharmacology 72 (3), 725-733, 2007 | 63 | 2007 |
| Thiazolidinediones mimic glucose starvation in facilitating Sp1 degradation through the up-regulation of β-transducin repeat-containing protein S Wei, HC Chuang, WC Tsai, HC Yang, SR Ho, AJ Paterson, SK Kulp, ... Molecular pharmacology 76 (1), 47-57, 2009 | 59 | 2009 |
| Development of novel adenosine monophosphate-activated protein kinase activators JH Guh, WL Chang, J Yang, SL Lee, S Wei, D Wang, SK Kulp, CS Chen Journal of medicinal chemistry 53 (6), 2552-2561, 2010 | 57 | 2010 |
| α-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis PH Huang, D Wang, HC Chuang, S Wei, SK Kulp, CS Chen Carcinogenesis 30 (7), 1125-1131, 2009 | 51 | 2009 |
| Peroxisome proliferator-activated receptor γ-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells CC Yang, CY Ku, S Wei, CW Shiau, CS Chen, JJ Pinzone, MD Ringel, ... Molecular Pharmacology 69 (5), 1564-1570, 2006 | 51 | 2006 |
| Targeting the Oncogenic E3 Ligase Skp2 in Prostate and Breast Cancer Cells with a Novel Energy Restriction-Mimetic Agent S Wei, PC Chu, HC Chuang, WC Hung, SK Kulp, CS Chen PLOS ONE 7 (10), e47298, 2012 | 38 | 2012 |
| Pharmacological exploitation of the peroxisome proliferator-activated receptor γ agonist ciglitazone to develop a novel class of androgen receptor-ablative agents J Yang, S Wei, DS Wang, YC Wang, SK Kulp, CS Chen Journal of medicinal chemistry 51 (7), 2100-2107, 2008 | 34 | 2008 |
| Pin1‐targeted therapy for systemic lupus erythematosus S Wei, N Yoshida, G Finn, S Kozono, M Nechama, VC Kyttaris, ... Arthritis & Rheumatology 68 (10), 2503-2513, 2016 | 32 | 2016 |
| Author Correction: The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation M Nechama, J Kwon, S Wei, A Tun-Kyi, RS Welner, IZ Ben-Dov, ... nature communications 14, 2023 | | 2023 |
Kun Ping LuWestern University在 uwo.ca 的电子邮件经过验证
